Mònica Vilà-Ubach

Therapeutic targeting of the RB1 pathway in retinoblastoma with the oncolytic adenovirus VCN-01

Guillem Pascual‐Pasto, Miriam Bazán‐Peregrino, Nagore G. Olaciregui et al. · Science Translational Medicine · 2019 · 109 citations

The PARP inhibitor olaparib enhances the sensitivity of Ewing sarcoma to trabectedin

José Luis Ordóñez, Ana Teresa Amaral, Ángel M. Carcaboso et al. · Oncotarget · 2015 · 96 citations · Full text

SPARC-mediated long-term retention of nab-paclitaxel in pediatric sarcomas

Guillem Pascual‐Pasto, Helena Castillo‐Ecija, Nora Unceta et al. · Journal of Controlled Release · 2021 · 51 citations

Oncology, Medicine, Pharmacotherapy +3

Targeted drug distribution in tumor extracellular fluid of GD2-expressing neuroblastoma patient-derived xenografts using SN-38-loaded nanoparticles conjugated to the monoclonal antibody 3F8

Carles Monterrubio, Sonia Paco, Nagore G. Olaciregui et al. · Journal of Controlled Release · 2017 · 46 citations · Full text

Nanoparticles, Nanomedicine, Drug Targeting +11

SN-38-loaded nanofiber matrices for local control of pediatric solid tumors after subtotal resection surgery

Carles Monterrubio, Guillem Pascual‐Pasto, Francisco Cano et al. · Biomaterials · 2015 · 43 citations · Full text

Tissue Engineering, Nanoparticles, Engineering +12